BATESWHITE.COM Grifols acquisition of Talecris CASE STUDY Client GRIFOLS Industry HEALTHCARE In June 2010, Barcelona-based Grifols SA (Grifols) agreed to purchase North Carolina- based Talecris Biotherapeutics (Talecris), a deal that at the time was valued at $3.4 billion. 1 Both companies develop, produce, and market blood plasma-derived products used in the treatment of bleeding and immune deficiency disorders. The FTC conducted an investiga

Join for free to read